The minister still hasn't answered one of the questions I asked her, and that is on post-market surveillance of drugs. There is funding needed for research into drugs, their interactions, their reactions, and their effectiveness, which I think requires funding. The Health Council of Canada suggested that recently in their report.
Secondly, the fact is that the Ministry of Health lacks a regulatory ability to deal with post-market surveillance in an appropriate manner. I didn't talk about regulation for drug shortages, Minister. I think you got my question wrong. This is post-market surveillance I'm speaking about, which is a different thing entirely.